![Gregory Flesher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregory Flesher
Chief Executive Officer at
Reneo Pharma Ltd.
Profile
Gregory J.
Flesher is President, Chief Executive Officer & Director at Reneo Pharma Ltd. Formerly, Mr. Flesher was Chief Executive Officer & Director at Otic Pharma Ltd. from 2015 to 2017, Chief Executive Officer & Director at Eledon Pharmaceuticals, Inc. from 2017 to 2020, President, Chief Executive Officer & Director at Reneo Pharmaceuticals, Inc., President & Chief Executive Officer at OnKure Therapeutics, Inc., Chief Executive Officer at Ambros Therapeutics, Inc., Director-Hepatology Sales & Pulmonary Marketing at InterMune, Inc. from 2002 to 2006, Director at Adynxx, Inc. from 2019 to 2021, and Chief Business Officer & SVP-Corporate Development at Avanir Pharmaceuticals, Inc. from 2011 to 2015.
Education includes undergraduate studies at Purdue University and The Indiana University School of Medicine.
Gregory Flesher active positions
| Companies | Position | Start |
|---|---|---|
Reneo Pharma Ltd. | Chief Executive Officer | - |
Former positions of Gregory Flesher
| Companies | Position | End |
|---|---|---|
| ADYNXX, INC. | Director/Board Member | 01/06/2021 |
| ELEDON PHARMACEUTICALS, INC. | Chief Executive Officer | 04/09/2020 |
Otic Pharma Ltd.
 Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for ear indications | Chief Executive Officer | 01/05/2017 |
| AVANIR PHARMACEUTICALS INC | Corporate Officer/Principal | 01/01/2015 |
| INTERMUNE INC | Sales & Marketing | 01/01/2006 |
Training of Gregory Flesher
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
57
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for the treatment of nervous system disorder | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Otic Pharma Ltd.
Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for ear indications | Health Technology |
The Indiana University School of Medicine
 The Indiana University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Reneo Pharmaceuticals, Inc.
 Reneo Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases | Health Technology |
Eledon Pharmaceuticals, Inc.
 Eledon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Adynxx, Inc.
 Adynxx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company which develops and markets novel & disease-modifying products for treatment of pain and inflammation | Health Technology |
Reneo Pharma Ltd. |
- Stock Market
- Insiders
- Gregory Flesher
